Cumberland Pharmaceuticals
CPIX
33 hedge funds and large institutions have $18.1M invested in Cumberland Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 1 closing their positions.
3,038% more call options, than puts
Call options by funds: $1M | Put options by funds: $32K
1,300% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 1
316% more capital invested
Capital invested by funds: $4.36M → $18.1M (+$13.8M)
65% more funds holding
Funds holding: 20 → 33 (+13)
17.52% more ownership
Funds ownership: 13.12% → 30.64% (+18%)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.36M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.07M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$1M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$928K |
| 5 |
BAM
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
|
+$638K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$576K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$86.2K |
| 3 |
Two Sigma Investments
New York
|
-$61.8K |
| 4 |
BlackRock
New York
|
-$41.1K |
| 5 |
Renaissance Technologies
New York
|
-$15.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $22.6K | -$11.9K | -2,858 | -35% |
|
27
Morgan Stanley
New York
| $11.3K | – | – | – |
|
|
CC
28
Centiva Capital
New York
| $6.77K | +$6.63K | +1,600 | New |
|
|
CAL
29
Capital Advisors Ltd
Shaker Heights,
Ohio
| $2K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $1.06K | – | – | – |
|
31
Bank of America
Charlotte,
North Carolina
| $288 | +$12 | +3 | +5% |
|
32
JP Morgan Chase
New York
| $80 | – | – | – |
|
|
HNB
33
Huntington National Bank
Columbus,
Ohio
| $4 | – | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$5.26K | -2,218 | Closed |
|
CPIX Hedge Fund Activity: Q1 2025 in Review
33 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2025, worth a combined $18.1M — up 316% from $4.36M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CPIX positions and 1 closed out — a net gain of 13 holders — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $3.36M. The largest seller was Acadian Asset Management, cutting an estimated $576K.
- 33 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2025, up from 20 in Q4 2024.
- Funds reported $18.1M of Cumberland Pharmaceuticals stock for Q1 2025, up 316% quarter-over-quarter.
- 14 funds opened new Cumberland Pharmaceuticals positions in Q1 2025 and 1 closed out, a net change of +13 holders.
- The largest Cumberland Pharmaceuticals buyer in Q1 2025 was Millennium Management, an estimated $3.36M added.
- The largest Cumberland Pharmaceuticals seller in Q1 2025 was Acadian Asset Management, an estimated $576K sold.
Based on aggregated 13F filings for Q1 2025.